Articles

PP2.1 Immunomodulatory effects of rapamycin in Graft versus Host Disease

BJH - volume 7, issue Abstract Book BHS, january 2016

G. Ehx , M. Hannon , S. Humblet-Baron , S. Dubois , C. Daulne , P. Drion , E. Willems MD, PhD, S. Servais MD, PhD, Y. Beguin MD, PhD, prof. F. Baron

Read more

PP3.2 Umbilical cord mesenchymal stromal cells are superior to bone marrow and adipose tissue-derived mesenchymal stromal cells for the treatment of xenogeneic graft-versus-host disease in mice

BJH - volume 7, issue Abstract Book BHS, january 2016

C. Grégoire MD, Y. Beguin MD, PhD, M. Hannon , S. Dubois , B. Baudoux , A. Briquet PhD, C. Lechanteur PhD, G. Ehx , prof. F. Baron

Read more

Impact of graft source and composition on outcomes after allogeneic stem cell transplantation

BJH - volume 6, issue 4, october 2015

S. Servais MD, PhD, prof. F. Baron , Y. Beguin MD, PhD

summary

Since many graft-related factors may affect outcomes after allogeneic stem cell transplantation, graft selection is one of the crucial steps of transplant preparation. Optimal graft selection may offer the best chance of successful transplantation. Here, we reviewed the impact of graft-related factors on post transplant outcomes in light of new data that may help to refine the strategy for graft and graft source selection.

(BELG J HEMATOL 2015;6(4): 162–8)

Read more

P3.06 Immune Recovery after Allogeneic Hematopoietic Stem Cell Transplantation following Flu-TBI versus TLI-ATG Conditioning

BJH - volume 6, issue Abstract Book BHS, january 2015

M. Hannon , Y. Beguin MD, PhD, G. Ehx , S. Servais MD, PhD, L. Seidel , C. Graux MD, PhD, J. Maertens MD, PhD, T. Kerre MD, PhD, C. Daulne , M. De Bock , M. Fillet , A. Ory , E. Willems MD, PhD, A. Gothot MD, PhD, S. Humblet-Baron , prof. F. Baron

Read more

O.4 Impact of pre-transplant infusion of antithymocyte globulin (ATG-Fresenius) on immune recovery after high intensity conditioning allogeneic stem cell transplantation

BJH - volume 6, issue Abstract Book BHS, january 2015

S. Servais MD, PhD, C. Menten , Y. Beguin MD, PhD, C. Daulne , L. Delens , E. Willems MD, PhD, M. Hannon , prof. F. Baron

Read more

P3.03 Study of immune recovery in a randomized phase II trial of sequential double autologous transplantation with unmanipulated or AC133+ PBSC in patients with multiple myeloma

BJH - volume 6, issue Abstract Book BHS, january 2015

M. Hannon , S. Servais MD, PhD, R. Schots MD, PhD, E. Castermans , L. Seidel , A. Gothot MD, PhD, E. Baudoux MD, O. Giet PhD, N. Wanten , E. Willems MD, PhD, C. Daulne , I. Van Riet PhD, Y. Beguin MD, PhD, prof. F. Baron

Read more

P3.14 Effects of the immunomodulating peptide thymosin alpha 1 in multiple myeloma and immune reconstitution after hematopoietic stem cell transplantation in murine models

BJH - volume 6, issue Abstract Book BHS, january 2015

M. Binsfeld , M. Hannon , S. Humblet-Baron , Y. Beguin MD, PhD, prof. F. Baron , J. Caers MD, PhD

Read more